Therefore, these findings indicate that tumor-derived SPP1 signaling drives the polarization of APOE+ macrophages, which subsequently secrete TGF-β to establish an immunosuppressive microenvironment, contributing to the failure of immunotherapy in ICB-resistant ccRCC. The gene discussed is TGFB1; the disease is neoplasm.